Regulations.gov document
Final Decision on Withdrawal of MAKENA (Hydroxyprogesterone Caproate) and Eight…
Notice · FDA-2020-N-2029 · posted May 15, 2023
Key facts
| Document ID | FDA-2020-N-2029-0386 |
|---|---|
| Title | Final Decision on Withdrawal of MAKENA (Hydroxyprogesterone Caproate) and Eight Abbreviated New Drug Applications Following Public Hearing; Availability of Final Decision |
| Document type | Notice |
| Subtype | Withdrawal |
| Agency | FDA |
| Docket | FDA-2020-N-2029 |
| Posted | May 15, 2023 |
| Federal Register citation | 88 FR 30986 |
| FR document number | 2023-10264 |
| Effective date | May 15, 2023 |
At a glance
- 1–9 Pages
- 100–999 Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: